Status:

COMPLETED

Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)

Lead Sponsor:

Chugai Pharmaceutical

Conditions:

Rheumatoid Arthritis

Eligibility:

All Genders

20-75 years

Phase:

PHASE3

Brief Summary

The purpose of this study is to investigate the clinical efficacy and safety of MRA in a double-blind, parallel-group, controlled study using MRA or methotrexate (MTX) in rheumatoid arthritis (RA) pat...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • Diagnosis of RA based on the 1987 classification criteria of the American College of Rheumatology (ACR)
  • Disease duration of 6 months or more
  • Treated with 8 mg/week of MTX for at least 8 weeks immediately preceding enrollment, and continued on this treatment up to initiation of the study drug
  • Active disease at enrollment (less than 2 weeks before initiating treatment with a study drug), Which is defined as having at least 6 tender and 6 swollen joints among 49 and 46 joints stipulated by the Japanese Rheumatism Foundation's Drug Evaluation Committee and ESR at least 30 mm/hr and CRP not less than 1.0 mg/dL
  • Exclusion criteria
  • Assessed as having Class IV Steinbrocker functional activity in the 4 weeks preceding treatment with the study drug
  • Treated with infliximab, etanercept or leflunomide in the 12 weeks preceding treatment with the study drug
  • Received any of the following therapies in the 2 weeks preceding initiation of treatment with the study drug.
  • Administration of any DMARD or immunosuppressant other than MTX
  • Administration of corticosteroids exceeding 10 mg/day as prednisolone
  • Dose escalation or initiation of corticosteroids
  • Received any of the following therapies in the 4 weeks preceding treatment with the study drug
  • Plasma exchange therapy
  • Surgical treatment (operation, etc.)

Exclusion

    Key Trial Info

    Start Date :

    February 1 2004

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    April 1 2006

    Estimated Enrollment :

    127 Patients enrolled

    Trial Details

    Trial ID

    NCT00144521

    Start Date

    February 1 2004

    End Date

    April 1 2006

    Last Update

    February 2 2009

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

    Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA) | DecenTrialz